BOSTON and LONDON, August 10, 2016 /PRNewswire/ --
IDBS and Cancer Research Technology(CRT), the commercialization arm of Cancer Research UK, have collaborated to streamline plate correction in high throughput screening (HTS). The algorithm, developed by IDBS in response to CRT requirements and soon to be offered to all customers, enables
(Logo: http://photos.prnewswire.com/prnh/20150324/735754 )
Dr Fabrice Turlais and Cristina Alli from the screening group at CRT said, "In HTS it isn't uncommon to find small anomalies in assays, especially systematic signal distortions caused by environmental conditions or errors from automated liquid handling apparatus or plate readers. The algorithm helps with post-assay data correction: our analysis after an HTS campaign would usually take 4-5 days and we expect to be able to reduce that by at least 15% with the new tool."
The ActivityBase template enables the automated correction of fifty plates in two seconds, with researchers able to view and store both 'before' and 'after' data. The functionality is compatible with data containing control wells as well as for multiple plate layouts.
"This is a great example of the collaborative approach we deliver in support of our customers' requirements," said Laurence Painell, Vice President, Product Management & Marketing, IDBS. "We worked closely with CRT, listened to feedback from the organization and provided a solution which has already seen amazing results in terms of streamlining plate correction. The time and cost savings projected are significant and are testament to what can be achieved via a partnership approach."
IDBS is a leading global provider of advanced software for research and development (R&D) organizations to securely capture, manage, share and exploit structured and unstructured data. Our technology and domain expertise enable users to link data to data, data to people, and people to people, to drive innovation, achieve faster time to market and improve margins. Our diverse customer list includes R&D driven international companies in pharmaceuticals, biotechnology, agricultural sciences, chemicals, consumer goods, energy, engineering, food and beverage, and healthcare.
Founded in 1989, IDBS is headquartered in the United Kingdom with offices across Europe, Asia and the United States. IDBS remains a privately held company employing over 250 staff across the world and serving over 50,000 researchers in 25 countries - including over 80% of the top twenty pharmaceutical companies.
For more information, please visit http://www.idbs.com or follow us on Twitter @IDBSsoftware.
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All